99 related articles for article (PubMed ID: 19565921)
41. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
42. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer.
Pizzato M; Franchin E; Calvi P; Boschetto R; Colombo M; Ferrini S; Palù G
Gene Ther; 1998 Jul; 5(7):1003-7. PubMed ID: 9813672
[TBL] [Abstract][Full Text] [Related]
43. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy.
Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A
Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334
[TBL] [Abstract][Full Text] [Related]
44. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
Rainov NG
Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443
[TBL] [Abstract][Full Text] [Related]
45. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
Izquierdo M; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Cortés ML; Paz JF; Isla A; Blázquez MG
Gene Ther; 1996 Jun; 3(6):491-5. PubMed ID: 8789798
[TBL] [Abstract][Full Text] [Related]
46. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
47. Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.
Voges J; Weber F; Reszka R; Sturm V; Jacobs A; Heiss WD; Wiestler O; Kapp JF
Hum Gene Ther; 2002 Mar; 13(5):675-85. PubMed ID: 11916490
[No Abstract] [Full Text] [Related]
48. Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
Stockhammer G; Brotchi J; Leblanc R; Bernstein M; Schackert G; Weber F; Ostertag C; Mulder NH; Mellstedt H; Seiler R; Yonekawa Y; Twerdy K; Kostron H; De Witte O; Lambermont M; Velu T; Laneuville P; Villemure JG; Rutka JT; Warnke P; Laseur M; Mooij JJ; Boëthius J; Mariani L; Gianella-Borradori A
J Mol Med (Berl); 1997 Apr; 75(4):300-4. PubMed ID: 9151217
[No Abstract] [Full Text] [Related]
49. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
Prados MD; McDermott M; Chang SM; Wilson CB; Fick J; Culver KW; Van Gilder J; Keles GE; Spence A; Berger M
J Neurooncol; 2003 Dec; 65(3):269-78. PubMed ID: 14682377
[TBL] [Abstract][Full Text] [Related]
50. Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas.
Rath P; Shi H; Maruniak JA; Litofsky NS; Maria BL; Kirk MD
Curr Stem Cell Res Ther; 2009 Jan; 4(1):44-9. PubMed ID: 19149629
[TBL] [Abstract][Full Text] [Related]
51. Stem cell based glioblastoma gene therapy.
Altaner C; Altanerova V
Neoplasma; 2012; 59(6):756-60. PubMed ID: 22862177
[TBL] [Abstract][Full Text] [Related]
52. Gene stereotactic neurosurgery for recurrent malignant gliomas.
Colombo F; Zanusso M; Casentini L; Cavaggioni A; Franchin E; Calvi P; Palù G
Stereotact Funct Neurosurg; 1997; 68(1-4 Pt 1):245-51. PubMed ID: 9711724
[TBL] [Abstract][Full Text] [Related]
53. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
Jacobs A; Voges J; Reszka R; Lercher M; Gossmann A; Kracht L; Kaestle C; Wagner R; Wienhard K; Heiss WD
Lancet; 2001 Sep; 358(9283):727-9. PubMed ID: 11551583
[TBL] [Abstract][Full Text] [Related]
54. Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model.
VanderVeen N; Raja N; Yi E; Appelman H; Ng P; Palmer D; Zamler D; Dzaman M; Lowenstein PR; Castro MG
Hum Gene Ther Methods; 2016 Jun; 27(3):98-111. PubMed ID: 27056322
[TBL] [Abstract][Full Text] [Related]
55. A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma.
Barzon L; Pacenti M; Taccaliti A; Franchin E; Bruglia M; Boscaro M; Palù G
J Clin Endocrinol Metab; 2005 May; 90(5):2831-4. PubMed ID: 15713704
[TBL] [Abstract][Full Text] [Related]
56. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study.
Tiberghien P; Cahn JY; Brion A; Deconinck E; Racadot E; Hervé P; Milpied N; Lioure B; Gluckman E; Bordigoni P; Jacob W; Chiang Y; Marcus S; Reynolds C; Longo D
Hum Gene Ther; 1997 Mar; 8(5):615-24. PubMed ID: 9095412
[No Abstract] [Full Text] [Related]
57. NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction.
Venditti G; Di Ianni M; Falzetti F; Moretti L; Di Florio S; Tabilio A
J Hematother Stem Cell Res; 2003 Feb; 12(1):83-91. PubMed ID: 12662439
[TBL] [Abstract][Full Text] [Related]
58. Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK.
Palù G; Pizzato M; Bonaguro R; Colombo F
Methods Mol Med; 2000; 35():511-22. PubMed ID: 21390827
[TBL] [Abstract][Full Text] [Related]
59. MRI characteristics and histological changes in glioblastoma after gene therapy.
Weber FW; Floeth FW; Reifenberger G; Felsberg J; Aulich A; Kiwit JC; Bock WJ
Front Radiat Ther Oncol; 1999; 33():244-52. PubMed ID: 10549494
[No Abstract] [Full Text] [Related]
60. Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I/II study.
Oldfield EH; Ram Z; Chiang Y; Blaese RM
Hum Gene Ther; 1995 Jan; 6(1):55-85. PubMed ID: 7703288
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
